.jpg)
.png)
All
The lipid hypothesis states that elevated plasma cholesterol, more specifically, LDL cholesterol, has a causal role in the development of coronary heart disease and other cardiovascular diseases. This hypothesis has been debated for over 150 years. Cholesterol was first discovered in bile and in... more
Led by the efforts of Carl Orringer, MD, FNLA, the National Lipid Association (NLA) has released the updated NLA Self-Assessment Program (NLA-SAP). The new program — now available for purchase — improves on the already existing NLA product that will continue to... more
Cardiovascular disease (CVD) is the leading cause of death worldwide, accounting for nearly 18 million deaths in 2017 with 859,125 of those occurring in the United States – a number higher than death from all forms of cancer combined.(1) Unfortunately, this global number is anticipated to rise to... more
It is with great pleasure that we bring you this issue focusing on Clinical Conundrums in Special Populations. As Dr. Ito mentions in his Presidents Message the NLA has been very busy this year. In an effort to help clinical lipidologists we convened a panel of Clinical Lipidology experts to... more
When Tara Dall, MD, began her medical career, it was in 2001, after she graduated from medical school and completed her residency at the University of Wisconsin at Madison. She started as a family practice physician with no specialization in lipidology. That changed quickly, however, when she saw... more
CME Series on LDL-C, Lp(a), and ASCVD Risk Watch Now Program Title: Prioritizing Lp(a) Screening and LDL-C Lowering to Transform Cardiovascular Risk Across the ASCVD Continuum Session 1: Lp(a) and LDL-C: Why You Need to Address Both in ASCVD Session 2: Lp(a) and... more
View the June 2019 SWLA E-Newsletter by clicking here.